Ivan Chicano Wust

Mr. Ivan Chicano Wust

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2011 in PLOS ONE
Verified
Journal Article
Open access
PDF file
THThomas von Hahn
Thomas von Hahn
ASAndreas Schulze
Andreas Schulze
IWIvan Chicano Wust
Ivan Chicano Wust
BHBenjamin Heidrich
Benjamin Heidrich
TBThomas Becker
Thomas Becker
SCSandra Ciesek
Sandra Ciesek
The pan-protein kinase C (PKC) inhibitor sotrastaurin (AEB071) is a novel immunosuppressant currently in phase II trials for immunosuppression after solid organ transplantation. Besides T-cell activation, PKC affects numerous cellular processes that are potentially important for the replication of hepatitis B virus (HBV) and hepatitis C virus (HCV), major blood-borne pathogens prevalent in solid organ transplant recipients. This study uses state of the art virological assays to assess the direct, non-immune mediated effects of sotrastaurin on HBV and HCV. Most importantly, sotrastaurin had no pro-viral effect on either HBV or HCV. In the presence of high concentrations of sotrastaurin, well above those used clinically and close to levels where cytotoxic effects become detectable, there was a reduction of HCV and HBV replication. This reduction is very likely due to cytotoxic and/or anti-proliferative effects rather than direct anti-viral activity of the drug. Replication cycle stages other than genome replication such as viral cell entry and spread of HCV infection directly between adjacent cells was clearly unaffected by sotrastaurin. These data support the evaluation of sotrastaurin in HBV and/or HCV infected transplant recipients.

9 December 2024 in F1000Research
Verified
Journal Article
Open access
PDF file
IWIvan Chicano Wust
Ivan Chicano Wust
The haemorrhagic features of viral haemorrhagic fevers may be caused by common patterns of metabolic disturbances of the glucose and ascorbate homeostasis. Haemorrhages and vasculature disfunctions are a clinical feature not only of viral haemorrhagic fevers, but also in scurvy, diabetes and thrombotic microangiopathic haemolytic anaemia. Interestingly, the expression of glucose and ascorbate transporter Glut-1 on the erythrocyte membrane is associated with the inability to synthesize ascorbate and is restricted to that very species that are susceptible to filoviruses (primates, humans and fruit bats). Glut-1 may play a pivotal role in haemorrhagic fever pathogenesis. TIM-1 and TAM receptors have been recognized to enhance entry of Ebola, Lassa and Dengue viruses and viral interferences with TIM-1 could disturb its function, disturbing the expression of Glut-1. In those species not able to synthesize ascorbate and expressing Glut-1 on erythrocytes virus could interact with Glut-1 or other functionally related protein, and the influx of glucose into the cells would be severely impaired. As a consequence, transient hyperglycemia and a marked oxidative stress coupled with the high levels of glucose in plasma would be established, and then promote the activation of NF–κB transcription, exacerbating a pro-inflammatory response mediated by cytokines and chemokines: The inability to synthesize ascorbate is an Achilles Heel when trying to counteract the oxidative stress.

13 October 2023 in F1000Research
Verified
Journal Article
Open access
PDF file
IWIvan Chicano Wust
Ivan Chicano Wust
The haemorrhagic features of viral haemorrhagic fevers may be caused by common patterns of metabolic disturbances of the glucose and ascorbate homeostasis. Haemorrhages and vasculature disfunctions are a clinical feature not only of viral haemorrhagic fevers, but also in scurvy, diabetes and thrombotic microangiopathic haemolytic anaemia. Interestingly, the expression of glucose and ascorbate transporter Glut-1 on the erythrocyte membrane is associated with the inability to synthesize ascorbate and is restricted to that very species that are susceptible to Filoviruses (primates, humans and fruit bats). Glut-1 may play a pivotal role in haemorrhagic fever pathogenesis. TIM-1 and TAM receptors have been recognized to enhance entry of Ebola, Lassa and Dengue viruses and viral interferences with TIM-1 could disturb its function, disturbing the expression of Glut-1.

18 May 2023 in F1000Research
Verified
Journal Article
Open access
PDF file
IWIvan Chicano Wust
Ivan Chicano Wust
The haemorrhagic features of viral haemorrhagic fevers may be caused by common patterns of metabolic disturbances of the glucose and ascorbate homeostasis. Haemorrhages and vasculature disfunctions are a clinical feature not only of viral haemorrhagic fevers, but also in scurvy, diabetes and thrombotic microangiopathic haemolytic anaemia. Interestingly, the expression of glucose and ascorbate transporter Glut-1 on the erythrocyte membrane is associated with the inability to synthesize ascorbate and is restricted to that very species that are susceptible to Filoviruses (primates, humans and fruit bats). Glut-1 may play a pivotal role in haemorrhagic fever pathogenesis. TIM-1 and TAM receptors have been recognized to enhance entry of Ebola, Lassa and Dengue viruses and viral interferences with TIM-1 could disturb its function, disturbing the expression of Glut-1.

5 March 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
IWIvan Chicano Wust
Ivan Chicano Wust
Glucose and ascorbate transport and their opposite effects on the physiological processes, explain the pathophysiology of the Ebola virus. The virus impairs intracellularly the interferon (IFN) signalling. The present article will focus on the viral factors (VP24, VP35, VP40 proteins, nucleoprotein NP) that operate in the inner of the cell, subsequently to the viral entry. The haemorrhagic fever syndrome could be understood as a state of oxidative stress, driven by hyperglycaemia and the activation of NF-kB pathway and inflammatory cytokines. High glucose levels in plasma contributes to oxidative stress. It has also an inhibitory effect on Interferon (IFN) signalling. Conversely, ascorbate can counteract the IFN blocking exerted by the virus and interfere virus budding. A treatment strategy would focus on the administration of ascorbate and glutathione, glucose or insulin at convenience, in order to maintain constant and normal levels of glucose in plasma, to combat the oxidative and inflammatory stress.

23 September 2026 in Microbes & Immunity
Verified
Journal Article
Open access
PDF file
IWIvan Chicano Wust
Ivan Chicano Wust
The opposing effects of glucose and ascorbate transport on physiological processes may help explain Ebola virus disease pathophysiology. The virus impairs intracellular interferon (IFN) signalling. High plasma glucose levels contribute to oxidative stress and may also inhibit IFN signalling. Conversely, ascorbate may counteract the virus-mediated IFN blockade and interfere with viral budding. Dysregulation of glucose and ascorbate homeostasis may contribute to the pathophysiology of Ebola virus haemorrhagic fever by promoting oxidative stress, activation of the nuclear factor kappa B (NF-κB) pathway, and a cytokine storm. Hyperglycaemia commonly occurs in critically ill patients with Ebola virus haemorrhagic fever. Therefore, haemorrhagic fever syndrome could be understood as a state of oxidative stress driven by hyperglycaemia, NF-κB pathway activation, and inflammatory cytokines. A potential treatment strategy would focus on administering ascorbate and glutathione, together with glucose or insulin as appropriate, to maintain normal, stable plasma glucose levels and combat oxidative and inflammatory stress.